• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寡聚化在多聚谷氨酰胺扩增神经退行性疾病中的关键作用。

Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders.

作者信息

Sánchez Ivelisse, Mahlke Christian, Yuan Junying

机构信息

Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

Nature. 2003 Jan 23;421(6921):373-9. doi: 10.1038/nature01301.

DOI:10.1038/nature01301
PMID:12540902
Abstract

The expansion of a CAG repeat coding for polyglutamine in otherwise unrelated gene products is central to eight neurodegenerative disorders including Huntington's disease. It has been well documented that expanded polyglutamine fragments, cleaved from their respective full-length proteins, form microscopically visible aggregates in affected individuals and in transgenic mice. The contribution of polyglutamine oligomers to neurodegeneration, however, is controversial. The azo-dye Congo red binds preferentially to beta-sheets containing amyloid fibrils and can specifically inhibit oligomerization and disrupt preformed oligomers. Here we show that inhibition of polyglutamine oligomerization by Congo red prevents ATP depletion and caspase activation, preserves normal cellular protein synthesis and degradation functions, and promotes the clearance of expanded polyglutamine repeats in vivo and in vitro. Infusion of Congo red into a transgenic mouse model of Huntington's disease, well after the onset of symptoms, promotes the clearance of expanded repeats in vivo and exerts marked protective effects on survival, weight loss and motor function. We conclude that oligomerization is a crucial determinant in the biochemical properties of expanded polyglutamine that are central to their chronic cytotoxicity.

摘要

在其他不相关的基因产物中,编码聚谷氨酰胺的CAG重复序列的扩增是包括亨廷顿舞蹈症在内的八种神经退行性疾病的核心问题。有充分的文献记载,从各自全长蛋白质上切割下来的扩增聚谷氨酰胺片段,在受影响个体和转基因小鼠中形成显微镜下可见的聚集体。然而,聚谷氨酰胺寡聚物对神经退行性变的作用存在争议。偶氮染料刚果红优先结合含有淀粉样原纤维的β折叠片,并且能特异性抑制寡聚化并破坏预先形成的寡聚物。在此我们表明,刚果红对聚谷氨酰胺寡聚化的抑制作用可防止ATP耗竭和半胱天冬酶激活,维持正常的细胞蛋白质合成和降解功能,并促进体内外扩增聚谷氨酰胺重复序列的清除。在亨廷顿舞蹈症转基因小鼠模型出现症状很久之后,向其注入刚果红,可促进体内扩增重复序列的清除,并对生存、体重减轻和运动功能产生显著的保护作用。我们得出结论,寡聚化是扩增聚谷氨酰胺生化特性的关键决定因素,而这些特性是其慢性细胞毒性的核心。

相似文献

1
Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders.寡聚化在多聚谷氨酰胺扩增神经退行性疾病中的关键作用。
Nature. 2003 Jan 23;421(6921):373-9. doi: 10.1038/nature01301.
2
Effects of overexpression of huntingtin proteins on mitochondrial integrity.亨廷顿蛋白过表达对线粒体完整性的影响。
Hum Mol Genet. 2009 Feb 15;18(4):737-52. doi: 10.1093/hmg/ddn404. Epub 2008 Nov 27.
3
Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release.由于多聚谷氨酰胺扩展的截短型N端亨廷顿蛋白的表达而导致的蛋白酶体功能改变,通过线粒体细胞色素c释放激活半胱天冬酶,从而诱导细胞凋亡。
Hum Mol Genet. 2001 May 1;10(10):1049-59. doi: 10.1093/hmg/10.10.1049.
4
Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.突变亨廷顿蛋白的淀粉样蛋白形成:阈值、渐进性及正常多聚谷氨酰胺蛋白的募集
Somat Cell Mol Genet. 1998 Jul;24(4):217-33. doi: 10.1023/b:scam.0000007124.19463.e5.
5
Polyglutamine disease: acetyltransferases awry.多聚谷氨酰胺疾病:乙酰转移酶功能失常。
Curr Biol. 2002 Feb 19;12(4):R141-3. doi: 10.1016/s0960-9822(02)00709-1.
6
Modeling Polyglutamine Expansion Diseases with Induced Pluripotent Stem Cells.诱导多能干细胞在多聚谷氨酰胺扩展疾病建模中的应用。
Neurotherapeutics. 2019 Oct;16(4):979-998. doi: 10.1007/s13311-019-00810-8.
7
Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders.聚谷氨酰胺致病机制:亨廷顿舞蹈病及相关疾病统一机制的出现
Neuron. 2002 Aug 29;35(5):819-22. doi: 10.1016/s0896-6273(02)00872-3.
8
Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.表达突变全长亨廷顿舞蹈病(HD)互补DNA的转基因小鼠:亨廷顿舞蹈病运动变化和选择性神经元丢失的范例
Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1035-45. doi: 10.1098/rstb.1999.0456.
9
Towards a transgenic model of Huntington's disease in a non-human primate.迈向非人类灵长类动物亨廷顿舞蹈症转基因模型
Nature. 2008 Jun 12;453(7197):921-4. doi: 10.1038/nature06975. Epub 2008 May 18.
10
Properties of polyglutamine expansion in vitro and in a cellular model for Huntington's disease.亨廷顿舞蹈病体外及细胞模型中多聚谷氨酰胺扩增的特性
Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1013-9. doi: 10.1098/rstb.1999.0453.

引用本文的文献

1
Transient Interdomain Interactions Modulate the Monomeric Structural Ensemble and Self-Assembly of Huntingtin Exon 1.瞬时结构域间相互作用调节亨廷顿蛋白外显子1的单体结构集合和自组装。
Adv Sci (Weinh). 2025 Apr 28:e2501462. doi: 10.1002/advs.202501462.
2
is efficacious in models of Huntington's disease by reducing ER stress.通过减轻内质网应激,在亨廷顿舞蹈症模型中具有疗效。
Front Mol Biosci. 2025 Mar 19;12:1567932. doi: 10.3389/fmolb.2025.1567932. eCollection 2025.
3
Two novel DnaJ chaperone proteins CG5001 and P58IPK regulate the pathogenicity of Huntington's disease related aggregates.
两种新型 DnaJ 伴侣蛋白 CG5001 和 P58IPK 调节亨廷顿病相关聚集物的致病性。
Sci Rep. 2024 Sep 6;14(1):20867. doi: 10.1038/s41598-024-71065-3.
4
Transient interdomain interactions modulate the monomeric structural ensemble and self-assembly of Huntingtin Exon 1.瞬时结构域间相互作用调节亨廷顿蛋白外显子1的单体结构集合和自组装。
bioRxiv. 2024 Dec 11:2024.05.03.592468. doi: 10.1101/2024.05.03.592468.
5
Elucidation of Site-Specific Ubiquitination on Chaperones in Response to Mutant Huntingtin.阐明突变型亨廷顿蛋白响应下伴侣蛋白的位点特异性泛素化。
Cell Mol Neurobiol. 2023 Dec 15;44(1):3. doi: 10.1007/s10571-023-01446-1.
6
Uncovering Critical Roles for RNA in Neurodegeneration.揭示 RNA 在神经退行性变中的关键作用。
Mo Med. 2023 Sep-Oct;120(5):374-380.
7
Neurodegenerative Diseases: New Hopes and Perspectives.神经退行性疾病:新的希望和展望。
Curr Mol Med. 2024;24(8):1004-1032. doi: 10.2174/1566524023666230907093451.
8
HSF1 and Its Role in Huntington's Disease Pathology.HSF1 及其在亨廷顿病病理学中的作用。
Adv Exp Med Biol. 2023;1410:35-95. doi: 10.1007/5584_2022_742.
9
Emerging Therapies for Huntington's Disease - Focus on N-Terminal Huntingtin and Huntingtin Exon 1.亨廷顿病的新兴疗法——聚焦于N端亨廷顿蛋白和亨廷顿蛋白外显子1
Biologics. 2022 Sep 30;16:141-160. doi: 10.2147/BTT.S270657. eCollection 2022.
10
Targeting mitochondrial DNA polymerase gamma for selective inhibition of MLH1 deficient colon cancer growth.针对线粒体 DNA 聚合酶 γ 选择性抑制 MLH1 缺陷型结肠癌细胞生长。
PLoS One. 2022 Jun 3;17(6):e0268391. doi: 10.1371/journal.pone.0268391. eCollection 2022.